Senators advanced a controversial measure that would compel the Food and Drug Administration to play a greater role in regulating dietary supplements, a departure from agency custom that has rankled trade groups.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.